跳至主要内容
临床试验/NCT00623376
NCT00623376已完成2 期

Randomized Double Blind Cross Over Study Assessing the Effect of Cannabiniods on Spasticity in Spinal Cord Injured Persons :A Pilot Study

University of Manitoba1 个研究点 分布在 1 个国家开始时间: 2007年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
试验地点
1
主要终点
Ashworth scale in most involved group muscles

研究概览

简要总结

Objectives: To determine whether nabilone, a synthetic cannabinoid, alleviates spasticity in people with spinal cord injury (SCI).

Methods: Twelve subjects were enrolled in this double-blind, placebo-controlled, crossover study. They received either nabilone or placebo during the first four-week period (0.5mg OD with option to increase to 0.5mg BID), then outcome measures were assessed. After a two-week washout, subjects were crossed-over to the opposite arm.

The primary outcome was the Ashworth scale for spasticity in the most involved muscle group, chosen by the subject and clinician. The secondary outcomes included Spasm Frequency Scale, Visual Analog Scale, Wartenberg Pendulum Test, sum of the Ashworth Scale in eight muscle groups of each side of the body, and the Clinician's and Subject's Global Impression of Change .

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with spinal cord injury were eligible for the study if they are 18-65 years old, have C5 (ASIA A-D) and below and the injury occurred greater than 1 year previously. They had to have stable neurological level of injury with moderate spasticity (Ashworth >/= 3) and no cognitive impairments. The spasticity medications needed to be unchanged for at least 30 days before inclusion, and no botulinum toxin injections for > 4 months.

排除标准

  • •They were excluded if they had:
  • •Heart disease as cannabinoids can reduce heart rate and blood pressure
  • •History of psychotic disorders, schizophrenia or any active psychological disorder
  • •Previously documented sensitivity to marijuana or other cannabinoid agents
  • •Severe liver dysfunction
  • •Cognitive impairment
  • •Major illness in another body area
  • •If they were pregnant or nursing mother
  • •Had history of drug dependency
  • •Used smoked cannabis < 30 days before the onset of the study or were unwilling not to smoke during the study; OR
  • •If they fixed tendon contractures

研究组 & 干预措施

1

Active Comparator

first on treatment then on Placebo

干预措施: nabilone then placebo (Drug)

2

Placebo Comparator

first on placebo then on treatment

干预措施: placebo then nabilone (Drug)

结局指标

主要结局

Ashworth scale in most involved group muscles

时间窗: 10 weeks

次要结局

  • The secondary outcomes included Spasm Frequency Scale, Visual Analog Scale, Wartenberg Pendulum Test, sum of the Ashworth Scale in eight muscle groups of each side of the body, and the Clinician's and Subject's Global Impression of Change .(10 weeks)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验